Sprintec and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sprintec (ethinyl estradiol; norgestimate) and Fenofibrate (fenofibrate). Common drug interactions include erythema among females and angina pectoris among males.

The phase IV clinical study analyzes what interactions people have when they take Sprintec and Fenofibrate. It is created by eHealthMe based on reports of 8 people who take the same drugs from the FDA, and is updated regularly.

What is Sprintec?

Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

On Mar, 24, 2026

8 people who take Sprintec and Fenofibrate together, and have interactions are studied.

Sprintec and Fenofibrate drug interactions.

What are the common drug interactions of Sprintec and Fenofibrate, by gender? *:

female:

Erythema (redness of the skin)
Injection site erythema (redness at injection site)
Injection site pain
Injection site pruritus (severe itching at injection site)
Injection site swelling
Rash
Skin lesion
Somnolence (a state of near-sleep, a strong desire for sleep)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Blood glucose decreased

male:

Angina pectoris (chest pain due to ischemia of the heart muscle)
Back pain
Hyperprolactinaemia (abnormally high levels of prolactin in the blood)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Limb injury
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Plasma cell myeloma (cancer that begins in plasma cells)
Post-traumatic stress disorder
Pulmonary embolism (blockage of the main artery of the lung)

What are the common drug interactions of Sprintec and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Blood glucose decreased
Palpitations (feelings or sensations that your heart is pounding or racing)

30-39:

Erythema (redness of the skin)
Injection site erythema (redness at injection site)
Injection site pain
Injection site pruritus (severe itching at injection site)
Injection site swelling
Rash
Skin lesion
Somnolence (a state of near-sleep, a strong desire for sleep)
Cough
Ear pain

40-49:

n/a

50-59:

n/a

60+:

Angina pectoris (chest pain due to ischemia of the heart muscle)
Back pain
Hyperprolactinaemia (abnormally high levels of prolactin in the blood)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Limb injury
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Plasma cell myeloma (cancer that begins in plasma cells)
Post-traumatic stress disorder
Pulmonary embolism (blockage of the main artery of the lung)

* Approximation only. Some reports may have incomplete information.

Do you take Sprintec and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously